Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans

Microbial Pathogenesis

Volumn 34, Issue 2, 2003, Pages 91-101

  Snyder, D Scott ^a   Small, P L C ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Calcium; Confocal microscopy; Macrolide; Mycolactone; Signal transduction

Indexed keywords

BODIPYMYCOLACTONE; CALCIUM ION; CASPASE; LACTONE DERIVATIVE; MACROLIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CALCIUM CELL LEVEL; CHELATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DERIVATIZATION; DRUG MECHANISM; ENZYME INDUCTION; FIBROBLAST CULTURE; MEMBRANE BINDING; MITOCHONDRIAL MEMBRANE; MYCOBACTERIUM ULCERANS; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ACTINOBACTERIA (CLASS); ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM ULCERANS; UNCULTURED ACTINOMYCETE;

EID: 0037291137     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0882-4010(02)00210-3     Document Type: Article

References (24)

1. McCallum P., Buckle G., Sissons H.A., Buckle G., Tolhurst J.C. A new mycobacterial infection in man: clinical aspects. J Pathol Bacteriol. 60:1948;93-122.
2. Horsburgh CR Jr., Meyers WM. Pathology of emerging infections American Society for Microbiology Press, Herndon VA, p. 132.
3. George K.M., Chatterjee D., Gunawardana G., Welty D., Hayman J., Lee R., Small P.I. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science. 283:1999;854-857.
4. George K.M., Pascopella L., Welty D., Small P.L.C. A Mycobacterium ulceran: toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immun. 68:2000;877-883.
5. George K.M., Barker L.P., Welty D., Small P.L.C. Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans. Infect Immun. 66:1998;587-593.
6. Pahlevan A.A., Wright D.J., George K.M., Small P.L.C., Foxwell B.M. The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function. J Immunol. 163:1999;3928-3935.
7. Raetz C.R.H. Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction. J Bacteriol. 175:1993;5745-5753.
8. Richter C. Pro-oxidants and mitochondrial Ca their relationship to apoptosis and oncogenesis. FEBS Lett. 325:1993;104-107.
9. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
10. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 262:1987;5592-5595.
11. Wang K.K., Nath R., Posner A., Raser K.J., Buroker-Kilgore M., Hajimohammadreza I., Probert A.W. Jr, Marcoux F.W., Ye Q., Takano E., Hatanaka M., Maki M., Caner H., Collins J.L., Fergus A., Lee K.S., Lunney E.A., Hays S.J., Yuen P. An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. Proc Natl Acad Sci USA. 93:1996;6687-6692.
12. Freissmuth M., Boehm S., Beindl W., Nickel P., Ijzerman A., Hohenegger M., Nanoff C. Suramin analogues as subtype-selective G protein inhibitors. Mol Pharmacol. 49:1996;602-611.
13. Igarashi M., Strittmatter S.M., Vartanian T., Fishman M.C. Mediation by G proteins of signals that cause collapse of growth cones. Science. 259:1993;77-79.
14. Wymann M., Arcaro A. Platelet-derived growth factor-induced phosphatidylinositol 3-kinase activation mediates actin rearrangements in fibroblasts. Biochem J. 298:1994;517-520.
15. Marks A.R. Intracellular calcium release channels; regulators of cell life and death. Am J Physiol. 272:(2):1997;H597-H605.
16. Pastorino J.G., Simbula G., Yamamoto G., Glascott P.A. Jr, Rothman R.J., Farber J.L. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem. 271:1996;29792-29798.
17. Snyder D.S., Small P.L. Staining of cellular mitochondria with LDS-751. J Immunol Meth. 257:2001;35-40.
18. Ajl S., Kadis S., Montie T.C. Microbial toxins. vols. 1-3:1970;Academic Press, San Diego, CA.
19. Heitman J., Movva N.R., Hall M.N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 253:1991;905-909.
20. Sabers C.J., Martin M.M., Brunn G.J., Williams J.M., Dumont F.J., Wiederrecht G., Abraham R.T. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem. 270:1995;815-822.
21. Vilella-Bach M., Nuzzi P., Fang Y., Chen J. The FKBP12-rapamycin-binding domain is required for FKBP12-rapamycin - associated protein kinase activity and G1 progression. J Biol Chem. 274:1999;4266-4272.
22. King R.B. Modeling of membrane transport. Adv Food Nutr Res. 40:1996;243-262.
23. Denecker G., Vandenabeele P., Grooten J., Penning L.C., Declercq W., Beyaert R., Buurman W.A., Fiers W. Differential role of calcium in tumour necrosis factor-mediated apoptosis and secretion of granulocyte-macrophage colony-stimulating factor in a T cell hybridoma. Cytokine. 9:1997;631-638.
24. Genestier L., Dearden-Badet M.T., Bonnefoy-Berard N., Lizard G., Revillard J.P. Cyclosporin A and FK506 inhibit activation-induced cell death in the murine WEHI-231 B cell line. Cell Immunol. 155:1994;283-291.